Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Events, Stroke, and Mortality in Patients with Type 2 Diabetes

被引:0
|
作者
Kawada, Tomoyuki [1 ]
机构
[1] Nippon Med Sch, Dept Hyg & Publ Hlth, 1 1 5 Sendagi Bunkyo Ku, Tokyo 1138602, Japan
关键词
OUTCOMES;
D O I
10.1007/s10557-022-07374-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:619 / 620
页数:2
相关论文
共 50 条
  • [1] Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Events, Stroke, and Mortality in Patients with Type 2 Diabetes
    Tomoyuki Kawada
    Cardiovascular Drugs and Therapy, 2023, 37 : 619 - 620
  • [2] Cardiovascular Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Adults With Type 2 Diabetes
    Woo, Vincent C.
    CANADIAN JOURNAL OF DIABETES, 2020, 44 (01) : 61 - 67
  • [3] Effects of sodium-glucose cotransporter-2 inhibitors on the cardiovascular and renal complications of type 2 diabetes
    Chilton, Robert J.
    DIABETES OBESITY & METABOLISM, 2020, 22 (01): : 16 - 29
  • [4] Cardiovascular effects and mechanisms of sodium-glucose cotransporter-2 inhibitors
    Yang Fan
    Meng Ran
    Zhu Da-Long
    慢性疾病与转化医学(英文), 2020, 06 (04) : 239 - 245
  • [5] The pleiotropic cardiovascular effects of sodium-glucose cotransporter-2 inhibitors
    Tanna, Monique S.
    Goldberg, Lee R.
    CURRENT OPINION IN CARDIOLOGY, 2021, 36 (06) : 764 - 768
  • [6] Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes in patients with atrial fibrillation and type 2 diabetes mellitus
    Oh, Y. S.
    Choi, Y.
    Kim, S. H.
    Kim, S. H.
    Park, S. Y.
    Kim, H. J.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [7] Sodium-glucose cotransporter-2 inhibitors in patients without diabetes
    Fryml, Elise
    Lanktree, Matthew B.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2023, 195 (17) : E619 - E619
  • [8] Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With CKD and Type 2 Diabetes
    Fu, Edouard
    D'Andrea, Elvira
    Wexler, Deborah J.
    Patorno, Elisabetta
    Paik, Julie M.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 673 - 673
  • [9] Obesity as a modifier of the cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes
    Suissa, Karine
    Schneeweiss, Sebastian
    Douros, Antonios
    Yin, Hui
    Patorno, Elisabetta
    Azoulay, Laurent
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 192
  • [10] Effects of sodium-glucose cotransporter-2 inhibitors on appetite markers in patients with type 2 diabetes mellitus
    McMillin, Sara M.
    Pham, Mimi L.
    Sherrill, Christina H.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2021, 31 (08) : 2507 - 2511